The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.
RSS Feed for InvestorBrandNetwork (IBN)March 10, 2026 — This article has been disseminated on behalf of Nevada Organic Phosphate Inc. and may include paid advertising.
March 10, 2026 — Soligenix (NASDAQ: SNGX) announced that SGX945 (dusquetide) has received Promising Innovative Medicine (“PIM”) designation from the U. K.
March 10, 2026 — Uranium Energy (NYSE American: UEC) announced that it has filed its Quarterly Report on Form 10-Q for the quarter ended Jan. 31, 2026, highlighting progress across its U.
March 10, 2026 — This article has been disseminated on behalf of McEwen Inc. and may include paid advertising.
March 10, 2026 — This article has been disseminated on behalf of MAX Power Mining and may include paid advertising. MAX Power Mining (CSE: MAXX; OTC: MAXXF; FRANKFURT: 89N) has adopted a Shareholder Rights Plan and entered into a Shareholder Rights Plan Agreement with TMX Trust Company as rights agent, effective immediately.
March 9, 2026 — Lawmakers in Washington State have approved a proposal that would allow patients with terminal illnesses to use medical marijuana in certain healthcare facilities, including hospices, hospitals, and nursing homes. The measure now awaits action from Governor Bob Ferguson.
March 9, 2026 — LIXTE Biotechnology Holdings and the company’s subsidiary, Liora Technologies, both develop products that aim to improve outcomes for cancer patients Specifically, Liora’s Linac for Image Guided Hadron Therapy (“LiGHT”) System and LIXTE’s LB-100 work together to fight cancer As a result, the companies are building a new cancer care ecosystem that hopes to boost the effectiveness of treatments, while also help them be more accessible for a wider range of patients Recently, LIXTE Biotechnology Holdings Inc. (NASDAQ: LIXT), a clinical-stage pharmaceutical company, acquired Liora Technologies, a company that is aiming to transform cancer care with innovative compact proton therapy.
March 9, 2026 — Appointment of fusion researcher Fabrice David adds scientific oversight as commercialization plans advance. Travis Yakimishyn joins as Chief Electrical & Power Systems Officer to lead utility-scale integration.
March 9, 2026 — “The EMA’s positive opinion signifies an important step for Soligenix as we continue to advance the program,” says company CEO. The designation provides incentives that may include protocol assistance, reduced regulatory fees and up to 10 years of market exclusivity following approval.
March 9, 2026 — Ongoing digital monitoring could be about to solve one of modern medicine’s most frustrating access problems. Life-extending cancer immunotherapies exist and there are numerous patients who could benefit from such therapies, but a mandatory hospital stay requirement currently makes access to immunotherapy nigh impossible for rural and underserved patients.
March 9, 2026 — Financial services are at a tipping point. Artificial intelligence and modernization are no longer separate trends; they are now deeply connected, reshaping how banks and financial institutions operate, compete, and earn trust.
March 9, 2026 — On Thursday, the prices of gold and silver retreated sharply, putting the precious metals on course to end the week on a low. Several factors could be behind this price movement as the usual suspects, such as a surging USD and rising Treasury yields don’t sufficiently explain this price correction.
March 9, 2026 — Octane announced that the Octane Neuro Tech Forum 2026 will take place March 26-27, 2026, at VEA Newport Beach, A Marriott Resort & Spa in Newport Beach, California, bringing together industry leaders, clinicians, investors and entrepreneurs to advance innovation in neurotechnology. The event, part of Octane’s Innovation Event Series, will feature keynote speaker Dr.
March 9, 2026 — This article has been disseminated on behalf of Nicola Mining Inc. and may include paid advertising.
March 9, 2026 — The company’s core innovation, the HeartBeam System, is positioned as the first cable-free, high-fidelity ECG system capable of capturing the heart’s electrical signals from three distinct directions. HeartBeam’s strategy is built around addressing a long-standing gap in cardiac care.
March 9, 2026 — Wearable Devices (NASDAQ: WLDS), a technology growth company specializing in artificial intelligence-powered touchless sensing wearables, announced it will implement a one-for-three reverse split of its ordinary shares and tradable warrants, effective when trading begins on a split-adjusted basis on March 11, 2026. The action is intended to increase the company’s per-share trading price to regain compliance with the $1.
March 9, 2026 — HeartBeam (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing advanced cardiac insights, announced that its management team will attend several investor and industry conferences in March 2026. CEO Robert Eno and CFO Timothy Cruickshank will participate in the virtual Oppenheimer 36th Annual Healthcare MedTech & Services Conference on March 16-17, including a webcast presentation on March 16, while also meeting with institutional and retail investors.
March 9, 2026 — This article has been disseminated on behalf of SPARC AI Inc. and may include paid advertising.
March 9, 2026 — This article has been disseminated on behalf of G Mining Ventures Corp. and may include paid advertising.
March 9, 2026 — NRx Pharmaceuticals (NASDAQ: NRXP) announced that its subsidiary HOPE Therapeutics has opened a new clinic in Palm Beach, Florida, focused on treating depression and post-traumatic stress disorder through an interventional psychiatry approach that includes ketamine and other neuroplastic drugs, transcranial magnetic stimulation (TMS), hyperbaric oxygen therapy and physician-led psychotherapy. The facility expands HOPE’s growing network of clinics and builds on a nationwide partnership with neurocare AG to bring non-invasive neuroplastic therapies to patients.